Research into Acquired Drug Resistance in Patients with ALK+ NSCLC
Amanda Nerstad, SPACEWALK participant, with family By Daniel A. Saez, MSc, Treatment and Trials Navigator, GO2 for Lung Cancer One of the biggest concerns within the mutation positive non-small cell lung cancer (NSCLC) community is the concept [...]